Ubs Asset Management Americas Inc Savara Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Savara Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 125,815 shares of SVRA stock, worth $406,382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,815
Previous 119,674
5.13%
Holding current value
$406,382
Previous $482,000
10.58%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SVRA
# of Institutions
128Shares Held
158MCall Options Held
67.6KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$79 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$47 Million11.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$39.9 Million6.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.62MShares$27.9 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$26.3 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $368M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.